Alumis ALMS
NASDAQ ALMS
$7.90 +0.13 (+1.67%)
At close: Sep 21, 2026 · 4:00 PM EDT

Alumis (ALMS) Cash from Financing Activities (2023 - 2025)

Alumis' (ALMS) quarterly Cash from Financing Activities came in at $1.3 million in Q4 2025, up 26260.0% year-over-year from N/an in Q4 2024, and up 26260.0% quarter-over-quarter from $5000.0 in Q4 2024.

Analysis

Alumis (ALMS) Cash from Financing Activities (2023 - 2025) Analysis & Trends

Alumis (ALMS) has reported Cash from Financing Activities for 3 consecutive years, with $1.3 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 26260.0% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $236.5 million, a 51.97% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 99.58% from the prior year.
  • Cash from Financing Activities was $1.3 million for Q4 2025 at Alumis, up from $5000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $235.2 million in Q3 2024 and troughed at $5000.0 in Q4 2024.
  • A 3-year average of $74.8 million and a median of $29.7 million in 2023 frame the typical range for Cash from Financing Activities.
  • The widest YoY moves for Cash from Financing Activities: up 500221.28% in 2024, down 99.98% in 2024.
  • Over 3 years, Cash from Financing Activities stood at $29.7 million in 2023, then tumbled by 99.98% to $5000.0 in 2024, then soared by 26260.0% to $1.3 million in 2025.
  • The last three Cash from Financing Activities figures came in at $1.3 million (Q4 2025), $5000.0 (Q4 2024), and $235.2 million (Q3 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn -1.48 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 2.34 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn -426.70 Mn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn -1.22 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 14.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 36.24 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 1.30 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -181.51 Mn
10 Alumis 966.94 Mn 464.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.32 Mn
Dec 31, 2024 5,000.00
Sep 30, 2024 235.15 Mn
Jun 30, 2024 128.06 Mn
Mar 31, 2024 129.15 Mn
Dec 31, 2023 29.72 Mn
Sep 30, 2023 47,000.00
API Access

Alumis Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALMS&period=max&api_key=YOUR_API_KEY